Stay updated with breaking news from Patrick Ritschel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DURHAM, N.C., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today
World-class facility supports the company’s growth, and discovery and development of gene therapies for inherited retinal diseases ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Subretinal delivery of RS1 using AAV capsid that spreads laterally beyond the injection site overcomes challenges associated with intravitreal delivery ...
by Chantal Allam, NCBiotech writer — January 15, 2021 . DURHAM – There’s a new biotech startup in town, and it’s already generating a lot of buzz. Meet Atsena Therapeutics – a clinical-stage gene therapy company headquartered in Durham that’s on a mission to reverse and prevent blindness. Shortly after launching last April, it paid French pharmaceutical company Sanofi for exclusive rights to a gene therapy targeting Leber congenital amaurosis (LCA), a leading cause of blindness in children. That spurred investors to pour $55 million into Atsena – just months after it raised ...